# Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension

> **NCT03592667** · PHASE4 · UNKNOWN · sponsor: **University of Guadalajara** · enrollment: 20 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo - Cap

## Key facts

- **NCT ID:** NCT03592667
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-14
- **Primary completion:** 2021-04
- **Final completion:** 2021-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03592667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03592667, "Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03592667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*